Latest Manufacturing And Distribution News

Bioxyne Limited, through its subsidiary Breathe Life Sciences, has secured a significant supply agreement to enter Germany’s burgeoning medical cannabis market, promising at least A$5.6 million in revenue for FY2026.

Bioxyne Limited's subsidiary Breathe Life Sciences has achieved key GMP certifications across multiple international markets, paving the way for expanded operations in Europe, the UK, Canada, and Singapore. The company signals strong growth prospects for FY2026, with formal guidance expected in August.

Clarity Pharmaceuticals has partnered with SpectronRx to manufacture and distribute its lead prostate cancer diagnostic, Cu-64 SAR-bisPSMA, at commercial scale across the US. This agreement sets the stage for a seamless launch pending FDA approval.

ClearVue Technologies has inked a five-year exclusive manufacturing and distribution agreement with New Zealand’s Viridian Glass, marking its strategic entry into the New Zealand market with solar-integrated glazing solutions.

First Graphene has secured a multi-year exclusive deal to supply graphene-enhanced masterbatch for safety boots aimed at Southeast Asia’s mining sector, marking a significant step in commercialising advanced materials in industrial apparel.

Oldfields Holdings announces the resignation of its Chairman, Managing Director, CEO, and a Non-Executive Director, triggering an interim leadership phase as the company searches for new executives.

Uscom Limited reported a 14% rise in Q3 customer receipts to $0.73 million, even as cash reserves dropped 38% to $1.34 million, reflecting increased operating costs and global market pressures.

RLF AgTech has completed a $2.4 million capital raise through an Entitlement Issue and Shortfall Placement, positioning the company for growth in Australia’s agricultural sector.

Merino & Co’s successful IPO has injected $6.35 million into the company, enabling a strategic expansion of manufacturing capacity and securing a new facility in Western Australia. The company is now poised to scale globally with automated production and enhanced distribution capabilities.

Tissue Repair Limited reports initial patient enrolment in its pivotal Phase 3 trial for TR987®, alongside a robust 35% quarterly sales increase for its TR Pro+® product. The company is also advancing manufacturing and distribution strategies to support growth.

ClearVue Technologies has secured key manufacturing and distribution agreements across the Middle East, China, and the UK, while acquiring ROOTS Sustainable Agricultural Technologies to bolster its net zero ag-tech solutions.

Bioxyne Limited reports a remarkable 77% revenue increase in Q2 FY2025 alongside positive operating cash flow, setting the stage for international growth with upcoming UK export approvals and a planned European GMP facility.